APYX MEDICAL CORPORATION TO RELEASE SECOND QUARTER OF FISCAL YEAR 2023 FINANCIAL RESULTS ON AUGUST 10, 2023By ApyxMedical|2025-12-12T19:00:50+00:00June 29, 2023|
APYX MEDICAL CORPORATION ANNOUNCES FDA 510(K) CLEARANCE FOR THE RENUVION MICRO HANDPIECEBy ApyxMedical|2025-12-12T19:01:32+00:00June 14, 2023|
